Mats Ehinger

Medicine & Life Sciences

1. Mantle-Cell Lymphoma 100%
2. Acute Myeloid Leukemia 71%
3. Lymphoma, Large B-Cell, Diffuse 53%
4. Hematopoietic Stem Cells 50%
5. Hematopoiesis 41%
6. Osteopetrosis 39%
7. Residual Neoplasm 38%
8. Leukemia 38%
9. Bone Marrow 38%
10. Lymphoma 37%
11. Gaucher Disease 36%
12. Stem Cells 36%
13. Tumor Suppressor Genes 35%
14. Stem Cell Transplantation 31%
15. Mutation 29%
16. Rituximab 29%
17. Genes 28%
18. Flow Cytometry 28%
19. Cell Cycle 26%
20. Retinoblastoma Protein 26%
21. Cell Differentiation 26%
22. Survival 24%
23. K562 Cells 23%
24. Recurrence 23%
25. Glucosylceramidase 23%
26. Neoplasms 22%
27. Cell Line 21%
28. Apoptosis 21%
29. Bone Marrow Cells 20%
30. High-Throughput Nucleotide Sequencing 20%
31. Genetic Therapy 19%
32. Progression-Free Survival 19%
33. Cell Cycle Checkpoints 18%
34. Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 18%
35. B-Lymphoid Precursor Cells 16%
36. Uniparental Disomy 16%
37. Mouse Rps19 protein 15%
38. Hematopoietic Stem Cell Transplantation 15%
39. Phenotype 15%
40. Fine Needle Biopsy 15%
41. Growth 15%
42. Polymerase Chain Reaction 15%
43. Drug Therapy 15%
44. Bone Marrow Transplantation 14%
45. Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14%
46. Erythropoiesis 14%
47. Bone Marrow Failure Disorders 14%
48. Transforming Growth Factor beta1 14%
49. Cytokines 14%
50. Clone Cells 13%